Sort
326,823 grants matching “clinical trial”
Emory-CDC CTU
$3,165,957Jeffrey Lennox · Emory University · UM1 · FY2022 · AI
Project-002
$3,165,820Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2019 · AI
Optimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization
$3,165,675Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2021 · DA
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE
$3,165,569Tracy A Glauser · Cincinnati Childrens Hosp Med Ctr · U01 · FY2012 · NS
Bone Marrow Grafting for Leukemia and Lymphoma
$3,165,316Stanford University · P01 · FY2005 · CA
Diabetes Prevention Program Outcomes Study
$3,165,214Sarah E. Fowler · George Washington University · U01 · FY2009 · DK
The Four Repeat Tauopathy Neuroimaging Initiative
$3,164,662Adam L Boxer · University Of California, San Francisco · R01 · FY2017 · AG
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
$3,164,609Nikhil Wagle · Broad Institute, Inc. · U2C · FY2020 · CA
Leadership and Operations Center (LOC): Microbicide Trials Network
$3,164,556Sharon L Hillier · Magee-Women'S Res Inst And Foundation · UM1 · FY2021 · AI
Bronchiectasis and chronic airway infection
$3,164,321Kevin Fennelly · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Computing Services for the Division of Cancer Prevention
$3,164,003Terisa Davis · Information Management Services, Inc. · N03 · FY2013 · CA
Naltrexone Transdermal Patch - An Accessible, Patient-Focused Option to Treat OUD Relapse
$3,163,508Andrew Gardiner · Libero Pharma Limited · UG3 · FY2023 · DA
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
$3,162,825Heidi Krause-Steinrauf · George Washington University · U01 · FY2022 · DK
TAS::75 0849::TAS CLINICAL TRIALS MONITORING SERVICE
$3,162,781Barry Anderson · Theradex Systems, Inc. · N01 · FY2014 · CA
A Treatment for Patients with Jansens Metaphyseal Chondrodysplasia (JMC)
$3,162,551Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,162,086Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$3,161,534Brian Murphy · Niaid Extramural Activities · Z01 · FY2007 · AI
Buffalo Clinical and Translational Research Center
$3,161,454Timothy F Murphy · State University Of New York At Buffalo · UL1 · FY2015 · TR
Anti NMDA Receptor antibodes in adult brain dysfunction and fetal brain development: lessons from lupus
$3,160,921Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2022 · AI
UNC Center for AIDS Research
$3,160,409Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2010 · AI
Closed-Tube Nucleic Acid Diagnostic system
$3,159,259Iquum, Inc. · UC1 · FY2005 · AI
Hepatitis B Research Network - Data Coordination Center
$3,159,196Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · DK
Locomotor Experience Applied Post-Stroke (LEAPS)
$3,158,874University Of Florida · R01 · FY2005 · NS
Language is Medicine: A Caregiver-Implemented Language Intervention to Prevent Developmental Delay in Dine Toddlers
$3,158,761Joshuaa Dominic Allison-Burbank · Johns Hopkins University · R01 · FY2025 · MD
New Approaches to Dementia Heterogeneity
$3,158,487Bruce L Miller · University Of California, San Francisco · P30 · FY2019 · AG